MedPath
HSA Approval

BORYMYCIN CAPSULE 100 mg

SIN10266P

BORYMYCIN CAPSULE 100 mg

BORYMYCIN CAPSULE 100 mg

October 14, 1998

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01AA08

minocycline

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y. S. P. INDUSTRIES (M) SDN BHD

Active Ingredients

MINOCYCLINE HCl

100 mg

Minocycline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BORYMYCIN CAPSULE 100 mg - HSA Approval | MedPath